Abstract
Activation of the heregulin/HER2 pathway in oestrogen receptor (ER)-positive breast-cancer cells leads to suppression of oestrogen-receptor element (ERE)-driven transcription and disruption of oestradiol responsiveness, and thus contributes to progression of tumours to more invasive phenotypes. Here we report the identification of metastatic-associated protein 1 (MTA1), a component of histone deacetylase (HDAC) and nucleosome-remodelling complexes, as a gene product induced by heregulin-β1 (HRG). Stimulation of cells with HRG is accompanied by suppression of histone acetylation and enhancement of deacetylase activity. MTA1 is also a potent corepressor of ERE transcription, as it blocks the ability of oestradiol to stimulate ER-mediated transcription. The histone-deacetylase inhibitor trichostatin A blocks MTA1-mediated repression of ERE transcription. Furthermore, MTA1 directly interacts with histone deacetylase-1 and -2 and with the activation domain of ER-α. Overexpression of MTA1 in breast-cancer cells is accompanied by enhancement of the ability of cells to invade and to grow in an anchorage-independent manner. HRG also promotes interaction of MTA1 with endogenous ER and association of MTA1 or HDAC with ERE-responsive target-gene promoters in vivo. These results identify ER-mediated transcription as a nuclear target of MTA1 and indicate that HDAC complexes associated with the MTA1 corepressor may mediate ER transcriptional repression by HRG.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nass, S. J. & Davidson, N. E. The biology of breast cancer . Hematol. Oncol. Clin. N. Am. 13, 311– 332 (1999).
Muss, H. B. et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med. 330, 1260–1266 (1994).
Borg, A. et al. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Lett. 81, 137–144 (1994).
Wright, C. et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br. J. Cancer 65, 118–121 ( 1992).
Benz, C. C. et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24, 85–95 ( 1995).
Hynes, N. C. & Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198 , 165–184 (1994).
Pietras, R. J. et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10, 2435–2446 ( 1995).
Kumar, R., Mandal, M., Ratzkin, B. J., Liu, N. & Lipton, A. NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells J. Cell. Biochem. 62, 102–112 (1995).
Tang, C. K. et al. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res. 56, 3350–3358 (1996).
Adam, L. et al. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 273, 28238–28246 (1998).
Owen-Hughes, T. & Workman, J. L. Experimental analysis of chromatin function in transcription control. Crit. Rev. Eukaryot. Gene. Expr. 4, 403– 441 (1994).
Owen-Hughes, T., Utley, R. T., Cote, J., Peterson, C. L. & Workman, J. L. Persistent site-specific remodeling of a nucleosome array by transient action of the SWI/SNF complex. Science 273, 513–516 (1996).
Paranjape, S. M., Kamakaka, R. T. & Kadonaga, J. T. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu. Rev. Biochem. 63, 265–297 (1994).
Brownell, J. E. et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843–851 (1996).
Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L. & Ayer, D. E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341–347 ( 1997).
Laherty, C. D. et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349–356 (1997).
Xue, Y. et al. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell 2, 851–861 (1998).
Zhang, Y. et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924–1935 (1999).
Toh, Y. et al. Molecular analysis of a candidate metastasis-associated gene, MTA1, possible interaction with histone deacetylase 1. J. Exp. Clin. Cancer Res. 19, 105–111 (2000).
Toh, Y., Pencil, S. D. & Nicolson, G. L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269, 229–263 (1994).
Toh, Y. et al. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int. J. Cancer 74, 459–463 (1997).
Toh, Y., Kuwano, H., Mori, M., Nicolson, G. L. & Sugimachi, K. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br. J. Cancer 79, 1723–1726 (1999).
Kleene, R., Zdzieblo, J., Wege, K. & Kern, H-F. A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat. J. Cell Sci. 112, 2539– 2548 (1999).
Krane, I. M. & Leder, P. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12, 1781– 1788 (1996).
Henttu, P. M., Kalkhoven, E. & Parker, M. G. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17, 1832–1839 (1997).
Fan, S. et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354– 1356 (1999).
Berry, M., Nunez, A. M. & Chambon, P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl Acad. Sci USA 86, 1218–1222 (1989).
Dubik, D. & Shiu, R. P. C. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7, 1587–1594 (1992).
Lin, R. J. et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391, 811– 814 (1998).
Grignani, F. et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in leukaemia. Nature 391, 815–818 (1998).
Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597– 601 (1998).
Kouzarides, T. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40–48 (1999).
Yang, W. M., Inouye, C., Zeng, Y., Bearss, D. & Seto, E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl Acad. Sci. USA 93, 12845–12850 (1996).
Boffa, L. C., Vidali, G., Mann, R. S. & Allfrey, V. G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate . J. Biol. Chem. 253, 3364– 3366 (1978).
Yang, W. M., Yao, Y. L., Sun, J. M., Davie, J. R. & Seto, E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272, 28001–28007 (1997).
Adam, L., Vadlamudi, R., Mandal, M., Chernoff, J. & Kumar, R. Regulation of microfilament reorganization and invasiveness of breast cancer cells by p21-activated kinase-1 K299R. J. Biol. Chem. 275, 12041–12050 (2000).
Vadlamudi, R. et al. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J. Biol. Chem. 275, 36238–36244 (2000).
Braunstein, M., Rose, A. B., Holmes, S. G., Allis, C. D. & Broach, J. R. Transcritional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7, 592–604 (1993).
Hecht, A., Strahl-Bolsinger, S. & Grunstein, M. Spreading of transcriptional repressor SIR3 from telomeric heterochromatin. Nature 383, 92–96 (1996).
Wang, R. A. & Zhao, G. Q. Transforming growth factor beta signal transducer Smad2 is expressed in mouse meiotic germ cells, Sertoli cells, and Leydig cells during spermatogenesis. Biol. Reprod. 61, 999–1004 (1999).
Acknowledgements
We thank D. Allies for anti-acetylated H4 antibody, D. McDonnell for 3X-ERE TATA, P. Leder for heregulin transgenic mice, F. Claret for 5XGAL4, W. Wang for Gal4–MTA1 and anti-CHD4 antibody, D. Shapiro for ERE-reporter systems, M. R. Parker for AF1 and AF2 fusion-protein expression vectors, E. Seto for HDACs expression vectors, S. Roth for HDAC assay substrate and useful tips, D. Stern for HER2 constructs, M-C. Hung for the Gal4 system, W. Schmid for GRE–CAT promoter constructs, R. Kleene for anti-MTA1 antibody, and D. Reinberg for anti-MTA2 antibody. This study was supported by NIH grants CA80066, CA65746 and CA84456, by the Breast Cancer Research Program of The University of Texas M. D. Anderson Cancer Center (to R.K.), and by Cancer Center Core grant CA16672.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Figure S1
MTAI1 act as a global steroidal repressor. (PDF 20 kb)
Rights and permissions
About this article
Cite this article
Mazumdar, A., Wang, RA., Mishra, S. et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 3, 30–37 (2001). https://doi.org/10.1038/35050532
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/35050532
This article is cited by
-
Extracellular vesicles remodel tumor environment for cancer immunotherapy
Molecular Cancer (2023)
-
Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer
Journal of Biosciences (2022)
-
Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation
Cell Communication and Signaling (2019)
-
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells
Cell Communication and Signaling (2019)
-
Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer
Virchows Archiv (2016)